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DEVELOPMENT OF BIOCOMPATIBLE SMALL-MOLECULE SPACERS AS METAL 




Development and study of the magnetic nanoparticles for biological and 
clinical applications remains one of the challenging research areas in 
chemistry and materials science. The performance of these particles as, 
for example, drug delivery, MRI, hyperthermia or cell tracking agents, 
depends on their magnetic susceptibility. Their ability to form stable 
aqueous colloids, the mobility, and diffusion properties in biological 
media, rely on organic coating, which is usually composed of hydrophilic 
biocompatible polymers such as dextrans or poly(ethylene glycol)s. Some 
areas of biomedical imaging, labeling and delivery application can benefit 
from magnetic nanoparticles with higher mobility and penetration, 
stronger interaction with fluids and tissues, and that can be easily 
conjugated to biological molecules. The idea of this work was to develop 
a non-polymeric organic coating of an adjustable size, which might offer a 
simpler way to obtaining particles with these properties.  
  
Materials and methods 
Magnetite nanoparticles (3.2-7.5 nm) were obtained in surfactant-free 
colloidal form by high-temperature hydrolysis of iron(II,III) chelated 
alkoxides in homogeneous diethylene glycol solutions.   
[Fe(Hdeg)2] + 2[Fe(Hdeg)deg] +  4H2O →  Fe3O4 + 6H2deg 
 The products of syntheses readily form aqueous colloids which were 
characterized by the Dynamic Light Scattering (DLS) and zeta-potential 
methods; isolated nanopowders were characterized by X-ray 
diffractometry, TEM, combustion analysis FT-IR spectrometry and 
magnetic measurements. 
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X-ray diffractogram of 3.2, 4.8 and 
7.5 nm magnetite nanoparticles 
Large-area TEM image of 4 nm 
Fe3O4 particles. Scale bar = 20 nm  
High resolution TEM image of 4 nm 
Fe3O4 particles. Scale bar = 5 nm  
The DLS spectra of magnetite citrate colloid obtained  
at different pH decreasing in order: Red > Green > Blue 




























































































































































































































































































































































































































































































Magnetization vs temperature for 4.8 nm  
magnetite nanoparticles (B = 50 Oe) 
Magnetization vs field for 4.8 nm  
magnetite nanoparticles 
In order to identify small organic molecules which would strongly bind to the 
surface of iron oxide nanocrystals and efficiently stabilize their aqueous colloids, 
we studied reactions of maghemite nanoparticles with citric, tartaric and malic 
acids. The reactions were monitored by the Dynamic Light Scattering (DLS) and 
zeta-potential measurements.  The results are summarized in the table below 
which shows the pH values representing substantial aggregation and de-
aggregation events during titration of aqueous Fe2O3 colloids with 0.01M HCl and 
0.01M NaOH.  The reference peak* appears at 7-9 nm in the DLS spectra; pH↑ 









The results revealed that the carboxyl and the adjacent α-OH groups of these 
acids are involved in coordination with the nanoparticle surface and they are the 
major contributors to the stability of the resulting adducts against hydrolysis. The 
proposed binding geometries for tartrate and citrate ligands are shown in the 
scheme below. 
Changes during titration Citrate Tartrate Malate 
The reference peak* intensity 
turned > 90% (pH↑) 
7.4 7.8 8.8 
The reference peak* intensity is 
still > 90% (pH↓) 
4.9 7.2 Decomposes 
The reference peak* intensity 
turned 0% (pH↓) 
4.5 6.9 Decomposes 
















Modification of the ligands’ coordinating core by attaching the substituent with 
variable steric and amphiphilic properties was the next step of our work. 
Synthesis was performed by a base-catalyzed nucleophilic oxirane ring-opening 
addition reaction between dimethyl 5-hydroxyisophthalate (as a model) and allyl 
glycidyl ether, followed by ester hydrolysis. In order to obtain water-soluble 
capping ligands, oxidation of the allyl double bonds to 1,2-diol was carried out 
with basic permanganate. Products of organic syntheses after purification were 
characterized by 1H NMR, 13C and 2D NMR, electrospray MS (acids) and GC-
MS (esters) 
Cytotoxicity studies showed no reduction in viability after incubation of the 
synthesized compounds with HeLa cells.  The reported method can be extended 
to the synthesis of O-substituted derivatives of other hydroxyacids of potential 
applications in biology and medicine.  
Surface chemistry studies were done by addition of the calculated 
amount of organic ligands followed by precipitation and transferring 
adducts into aqueous systems. Acid-base titrations were accompanied 
by Dynamic Light Scattering and electrokinetic mobility measurements 
using Malvern Zetasizer Nano ZS instrument.   
